Loading…
Are all antibiotic persisters created equal?
Antibiotic persisters are a sub-population of bacteria able to survive in the presence of bactericidal antibiotic despite the lack of heritable drug resistance mechanisms. This phenomenon exists across many bacterial species and is observed for many different antibiotics. Though these bacteria are o...
Saved in:
Published in: | Frontiers in cellular and infection microbiology 2022-08, Vol.12, p.933458-933458 |
---|---|
Main Authors: | , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c465t-c7ce02317b34b49c60ceee175ff021578263d90338a0a06f426a4d458155ef2b3 |
---|---|
cites | cdi_FETCH-LOGICAL-c465t-c7ce02317b34b49c60ceee175ff021578263d90338a0a06f426a4d458155ef2b3 |
container_end_page | 933458 |
container_issue | |
container_start_page | 933458 |
container_title | Frontiers in cellular and infection microbiology |
container_volume | 12 |
creator | Shultis, Michael W Mulholland, Claire V Berney, Michael |
description | Antibiotic persisters are a sub-population of bacteria able to survive in the presence of bactericidal antibiotic despite the lack of heritable drug resistance mechanisms. This phenomenon exists across many bacterial species and is observed for many different antibiotics. Though these bacteria are often described as "multidrug persisters" very few experiments have been carried out to determine the homogeneity of a persister population to different drugs. Further, there is much debate in the field as to the origins of a persister cell. Is it formed spontaneously? Does it form in response to stress? These questions are particularly pressing in the field of
, where persisters may play a crucial role in the required length of treatment and the development of multidrug resistant organisms. Here we aim to interpret the known mechanisms of antibiotic persistence and how they may relate to improving treatments for
, exposing the gaps in knowledge that prevent us from answering the question: Are all antibiotic persisters created equal? |
doi_str_mv | 10.3389/fcimb.2022.933458 |
format | article |
fullrecord | <record><control><sourceid>proquest_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_f3bec105bd2e453c8eaaae02e64b2d86</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><doaj_id>oai_doaj_org_article_f3bec105bd2e453c8eaaae02e64b2d86</doaj_id><sourcerecordid>2709911794</sourcerecordid><originalsourceid>FETCH-LOGICAL-c465t-c7ce02317b34b49c60ceee175ff021578263d90338a0a06f426a4d458155ef2b3</originalsourceid><addsrcrecordid>eNpVkU1PGzEQQK2qqESUH8Cl2mMPTbDHH2tfWiEEBQmpFzhbY-9sarTJBntTqf--DkkR8cG27Jk3M3qMXQi-kNK6yz6mVVgAB1g4KZW2H9gMQOo5OGs_vrufsvNSnnldLQfr5Cd2Kg03wrYwY9-uMjU4DA2upxTSOKXYbCiXVKa6NzETTtQ19LLF4cdndtLjUOj8cJ6xp9ubx-u7-cOvn_fXVw_zqIye5rGNxEGKNkgVlIuGRyISre57DkK3FozsHK9TIEduegUGVVcnEFpTD0Gesfs9txvx2W9yWmH-60dM_vVhzEuPuXY6kO9loCi4Dh2Q0jJaQsRanYwK0FlTWd_3rM02rKiLtJ4yDkfQ4591-u2X4x_vFFjjdoCvB0AeX7ZUJr9KJdIw4JrGbfHQcueEaJ2qoWIfGvNYSqb-rYzgfifNv0rzO2l-L63mfHnf31vGf0XyH7VykxI</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2709911794</pqid></control><display><type>article</type><title>Are all antibiotic persisters created equal?</title><source>PubMed Central (PMC)</source><creator>Shultis, Michael W ; Mulholland, Claire V ; Berney, Michael</creator><creatorcontrib>Shultis, Michael W ; Mulholland, Claire V ; Berney, Michael</creatorcontrib><description>Antibiotic persisters are a sub-population of bacteria able to survive in the presence of bactericidal antibiotic despite the lack of heritable drug resistance mechanisms. This phenomenon exists across many bacterial species and is observed for many different antibiotics. Though these bacteria are often described as "multidrug persisters" very few experiments have been carried out to determine the homogeneity of a persister population to different drugs. Further, there is much debate in the field as to the origins of a persister cell. Is it formed spontaneously? Does it form in response to stress? These questions are particularly pressing in the field of
, where persisters may play a crucial role in the required length of treatment and the development of multidrug resistant organisms. Here we aim to interpret the known mechanisms of antibiotic persistence and how they may relate to improving treatments for
, exposing the gaps in knowledge that prevent us from answering the question: Are all antibiotic persisters created equal?</description><identifier>ISSN: 2235-2988</identifier><identifier>EISSN: 2235-2988</identifier><identifier>DOI: 10.3389/fcimb.2022.933458</identifier><identifier>PMID: 36061872</identifier><language>eng</language><publisher>Switzerland: Frontiers Media S.A</publisher><subject>Anti-Bacterial Agents - pharmacology ; Anti-Bacterial Agents - therapeutic use ; Cellular and Infection Microbiology ; multidrug ; mycobacteria ; Mycobacterium tuberculosis - genetics ; persistence ; persister ; tolerance ; tuberculosis</subject><ispartof>Frontiers in cellular and infection microbiology, 2022-08, Vol.12, p.933458-933458</ispartof><rights>Copyright © 2022 Shultis, Mulholland and Berney.</rights><rights>Copyright © 2022 Shultis, Mulholland and Berney 2022 Shultis, Mulholland and Berney</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c465t-c7ce02317b34b49c60ceee175ff021578263d90338a0a06f426a4d458155ef2b3</citedby><cites>FETCH-LOGICAL-c465t-c7ce02317b34b49c60ceee175ff021578263d90338a0a06f426a4d458155ef2b3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC9428696/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC9428696/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,27924,27925,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/36061872$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Shultis, Michael W</creatorcontrib><creatorcontrib>Mulholland, Claire V</creatorcontrib><creatorcontrib>Berney, Michael</creatorcontrib><title>Are all antibiotic persisters created equal?</title><title>Frontiers in cellular and infection microbiology</title><addtitle>Front Cell Infect Microbiol</addtitle><description>Antibiotic persisters are a sub-population of bacteria able to survive in the presence of bactericidal antibiotic despite the lack of heritable drug resistance mechanisms. This phenomenon exists across many bacterial species and is observed for many different antibiotics. Though these bacteria are often described as "multidrug persisters" very few experiments have been carried out to determine the homogeneity of a persister population to different drugs. Further, there is much debate in the field as to the origins of a persister cell. Is it formed spontaneously? Does it form in response to stress? These questions are particularly pressing in the field of
, where persisters may play a crucial role in the required length of treatment and the development of multidrug resistant organisms. Here we aim to interpret the known mechanisms of antibiotic persistence and how they may relate to improving treatments for
, exposing the gaps in knowledge that prevent us from answering the question: Are all antibiotic persisters created equal?</description><subject>Anti-Bacterial Agents - pharmacology</subject><subject>Anti-Bacterial Agents - therapeutic use</subject><subject>Cellular and Infection Microbiology</subject><subject>multidrug</subject><subject>mycobacteria</subject><subject>Mycobacterium tuberculosis - genetics</subject><subject>persistence</subject><subject>persister</subject><subject>tolerance</subject><subject>tuberculosis</subject><issn>2235-2988</issn><issn>2235-2988</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>DOA</sourceid><recordid>eNpVkU1PGzEQQK2qqESUH8Cl2mMPTbDHH2tfWiEEBQmpFzhbY-9sarTJBntTqf--DkkR8cG27Jk3M3qMXQi-kNK6yz6mVVgAB1g4KZW2H9gMQOo5OGs_vrufsvNSnnldLQfr5Cd2Kg03wrYwY9-uMjU4DA2upxTSOKXYbCiXVKa6NzETTtQ19LLF4cdndtLjUOj8cJ6xp9ubx-u7-cOvn_fXVw_zqIye5rGNxEGKNkgVlIuGRyISre57DkK3FozsHK9TIEduegUGVVcnEFpTD0Gesfs9txvx2W9yWmH-60dM_vVhzEuPuXY6kO9loCi4Dh2Q0jJaQsRanYwK0FlTWd_3rM02rKiLtJ4yDkfQ4591-u2X4x_vFFjjdoCvB0AeX7ZUJr9KJdIw4JrGbfHQcueEaJ2qoWIfGvNYSqb-rYzgfifNv0rzO2l-L63mfHnf31vGf0XyH7VykxI</recordid><startdate>20220817</startdate><enddate>20220817</enddate><creator>Shultis, Michael W</creator><creator>Mulholland, Claire V</creator><creator>Berney, Michael</creator><general>Frontiers Media S.A</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope></search><sort><creationdate>20220817</creationdate><title>Are all antibiotic persisters created equal?</title><author>Shultis, Michael W ; Mulholland, Claire V ; Berney, Michael</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c465t-c7ce02317b34b49c60ceee175ff021578263d90338a0a06f426a4d458155ef2b3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Anti-Bacterial Agents - pharmacology</topic><topic>Anti-Bacterial Agents - therapeutic use</topic><topic>Cellular and Infection Microbiology</topic><topic>multidrug</topic><topic>mycobacteria</topic><topic>Mycobacterium tuberculosis - genetics</topic><topic>persistence</topic><topic>persister</topic><topic>tolerance</topic><topic>tuberculosis</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Shultis, Michael W</creatorcontrib><creatorcontrib>Mulholland, Claire V</creatorcontrib><creatorcontrib>Berney, Michael</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>Frontiers in cellular and infection microbiology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Shultis, Michael W</au><au>Mulholland, Claire V</au><au>Berney, Michael</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Are all antibiotic persisters created equal?</atitle><jtitle>Frontiers in cellular and infection microbiology</jtitle><addtitle>Front Cell Infect Microbiol</addtitle><date>2022-08-17</date><risdate>2022</risdate><volume>12</volume><spage>933458</spage><epage>933458</epage><pages>933458-933458</pages><issn>2235-2988</issn><eissn>2235-2988</eissn><abstract>Antibiotic persisters are a sub-population of bacteria able to survive in the presence of bactericidal antibiotic despite the lack of heritable drug resistance mechanisms. This phenomenon exists across many bacterial species and is observed for many different antibiotics. Though these bacteria are often described as "multidrug persisters" very few experiments have been carried out to determine the homogeneity of a persister population to different drugs. Further, there is much debate in the field as to the origins of a persister cell. Is it formed spontaneously? Does it form in response to stress? These questions are particularly pressing in the field of
, where persisters may play a crucial role in the required length of treatment and the development of multidrug resistant organisms. Here we aim to interpret the known mechanisms of antibiotic persistence and how they may relate to improving treatments for
, exposing the gaps in knowledge that prevent us from answering the question: Are all antibiotic persisters created equal?</abstract><cop>Switzerland</cop><pub>Frontiers Media S.A</pub><pmid>36061872</pmid><doi>10.3389/fcimb.2022.933458</doi><tpages>1</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 2235-2988 |
ispartof | Frontiers in cellular and infection microbiology, 2022-08, Vol.12, p.933458-933458 |
issn | 2235-2988 2235-2988 |
language | eng |
recordid | cdi_doaj_primary_oai_doaj_org_article_f3bec105bd2e453c8eaaae02e64b2d86 |
source | PubMed Central (PMC) |
subjects | Anti-Bacterial Agents - pharmacology Anti-Bacterial Agents - therapeutic use Cellular and Infection Microbiology multidrug mycobacteria Mycobacterium tuberculosis - genetics persistence persister tolerance tuberculosis |
title | Are all antibiotic persisters created equal? |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-07T23%3A54%3A09IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Are%20all%20antibiotic%20persisters%20created%20equal?&rft.jtitle=Frontiers%20in%20cellular%20and%20infection%20microbiology&rft.au=Shultis,%20Michael%20W&rft.date=2022-08-17&rft.volume=12&rft.spage=933458&rft.epage=933458&rft.pages=933458-933458&rft.issn=2235-2988&rft.eissn=2235-2988&rft_id=info:doi/10.3389/fcimb.2022.933458&rft_dat=%3Cproquest_doaj_%3E2709911794%3C/proquest_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c465t-c7ce02317b34b49c60ceee175ff021578263d90338a0a06f426a4d458155ef2b3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2709911794&rft_id=info:pmid/36061872&rfr_iscdi=true |